References
- Kinoshita JH. Mechanism initiating cataract formation. iInvest Ophthalmol Vis Sci.i 1974;13:713–724.
- Kador PF. The role of aldose reductase in the develop-ment of diabetic complications. iMed Res Rev.i 1988;8: 325–352.
- Datiles M, Fukui H, Kuwabara T, Kinoshita JH. Galac-tose cataract prevention with sorbinil, an aldose reduc-tase inhibitor: a light microscopic study. iInvest Oph-thalmol Vis Sci.i 1982;22:174–179.
- Sato S, Takahashi Y, Wyman M, Kinoshita JH, Kador PF. Progression of sugar cataract in the dog. iInvest Oph-thalmol Vis Sci.i 1991;32:1925–1931.
- Unakar NJ, Tsui Y. Inhibition of galactose-induced al-ternations in ocular lens with sorbinil. iExp Eye Res.i 1983;36:685–694.
- Simard-Duquesne N, Greselin E, Gonzalez R, DvonikD. Prevention of cataract development in severely ga-lactosemic rats by aldose reductase inhibitor, tolrestat. iProc Soc Exp Riol Med.i 1985;178:599–605.
- Kador PF, Akagi Y, and Kinoshita JH. The effect of aldose reductase and its inhibition on sugar cataract for-mation. iMetabolism.i 1986;35:15–19.
- Unakar NJ, Tsui J, Johnson M. Aldose reductase inhibi-tors and prevention of galactose cataracts in rats. iInvest Ophthalmol Vis Sci.i 1989;30:1623–1632.
- Sato S, Mori K, Wyman M, Kador PF. Dose dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175. iExp Eye Res.i 1998;66:217–222.
- Berkowitz BA, Moriyama T, Fales HM, Byrd RA, Balaban RS. iIn vivoi metabolism of 3-deoxy-3-fluoro-D-glucose. iJ Riol Chem.i 1990;265: 12417–23.
- Karino K, Kador PF, Berkowitz B, Balaban RS (1991). 19F NMR quantitation of lens aldose reductase activity using 3-deoxy-3-fluoro-D-glucose. iJ Riol Chem.i 1991; 266:20970–75.
- Lizak MJ, Secchi EJ, Lee JW, Sato S, Kubo E, Akagi Y, Kador PF: Using 3-Fluoro-3-Deoxy-D-Glucose As Substrate for Investigating Flux Through the Polyol Pathway In Dog Lens by "Fluorine Nuclear Mag-netic Resonance (NMR). iInvest Ophthalmol Vis Sci.i in press.
- Sato S, Kador PF. NADPH-dependent reductases of the dog lens. iExp Eye Res.i 1990;50:629–634.
- Maret W; Auld DS. Purification and characterization of human liver sorbitol dehydrogenase. iBiochemistry.i 1988; 27:1622–1628.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utiliz-ing the principle of protein-dye binding. iAnal Biochem.i 1976;72:248–54.
- Nagata M, Hohman TC, Nishimura C, Drea CM, Oliver C, Robison WG Jr. Polyol and vacuole formation in cultured canine lens epithelial cells. iExp Eye Res.i 1989;48:667–77.
- Lin L-R, Reddy VN, Giblin FJ, Kador PF, Kinoshita JH. Polyol accumulation in cultured human lens epithelial cells. iExp Eye Resi 1991;52: 93–100.
- Nakada T; Kwee IL; Card PJ; Matwiyoff NA; Griffey By; Griffey RH. Fluorine-19 NMR imaging of glucose metabolism. iMagn Reson Med.i 1988;6:307–13.
- Pouremad R; Wyrwicz AM. Cerebral metabolism of fluorodeoxyglucose measured with 19F NMR spectros-copy. iNMR Biomed.i 1991;4:161–6.
- Kanazawa Y; Yamane H; Shinohara S; Kuribayashi S; Momozono Y; Yamato Y; Kojima M; Masuda K. 2-Deoxy-2-fluoro-D-glucose as a functional probe for NMR: the unique metabolism beyond its 6-phosphate. iJ Neurochem.i 1996;66:2113–20.
- Kanazawa, Y, Umayahara K, Shimmura T, Yamashita T. 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging. NMR Biomed 1997;10: 35–41.
- Nakada T, Kwee IL. Nonivasive analysis of aldose re-ductase activities in rat testis: 3-FDG NMR spectros-copy and imaging. iMagn Res Med.i 1993;29(4):543–5.
- Kwee, IL, Igarashi, H, Nakada, T. Aldose reductase and sorbitol dehydrogenase activities in diabetic brain: iin vivoi studies using 19F 3-FDG NMR in rats. iNeurochemistry.i 1996;7: 726–728.
- Shatton JB, Halver JE, Weinhouse S. Glucose (hexose 6-phosphate) dehydrogenase in liver of rainbow trout. iJ Biol Chem.i 1971;246: 4878–85.